Sekikawa T - Search Results

1

O(6)-methylguanine-DNA methyltransferase (MGMT) as a determinant of resistance to camptothecin derivatives.

Okamoto R, Takano H, Okamura T, Park JS, Tanimoto K, Sekikawa T, Yamamoto W, Sparreboom A, Verweij J, Nishiyama M. Okamoto R, et al. Among authors: sekikawa t. Jpn J Cancer Res. 2002 Jan;93(1):93-102. doi: 10.1111/j.1349-7006.2002.tb01205.x. Jpn J Cancer Res. 2002. PMID: 11802813 Free PMC article.

2

Cellular sensitivity determinants to docetaxel in human gastrointestinal cancers.

Park JS, Yamamoto W, Sekikawa T, Matsukawa M, Okamoto R, Sasaki M, Ukon K, Tanimoto K, Kumazaki T, Nishiyama M. Park JS, et al. Among authors: sekikawa t. Int J Oncol. 2002 Feb;20(2):333-8. Int J Oncol. 2002. PMID: 11788897 Free article.

3

[Decision making: how to choice anticancer chemotherapy].

Nishiyama M, Sekikawa T. Nishiyama M, et al. Among authors: sekikawa t. Nihon Rinsho. 2001 Apr;59 Suppl 4:344-9. Nihon Rinsho. 2001. PMID: 11424404 Review. Japanese. No abstract available.

4

Unique action determinants of double acting topoisomerase inhibitor, TAS-103.

Okamoto R, Takano H, Sekikawa T, Tanaka T, Toyada M, Ukon K, Tanimoto K, Kumazaki T, Nishiyama M. Okamoto R, et al. Among authors: sekikawa t. Int J Oncol. 2001 Nov;19(5):921-7. doi: 10.3892/ijo.19.5.921. Int J Oncol. 2001. PMID: 11604989

5

[Irinotecan chemotherapy for patients with advanced or relapsed pancreatic neoplasm].

Sekikawa T, Akaike A, Ushio J, Sato A, Matsukawa M. Sekikawa T, et al. Nihon Rinsho. 2006 Jan;64 Suppl 1:203-6. Nihon Rinsho. 2006. PMID: 16457250 Review. Japanese. No abstract available.

6

Regulation of survival and death of mesangial cells by extracellular matrix.

Sugiyama H, Kashihara N, Maeshima Y, Okamoto K, Kanao K, Sekikawa T, Makino H. Sugiyama H, et al. Among authors: sekikawa t. Kidney Int. 1998 Oct;54(4):1188-96. doi: 10.1046/j.1523-1755.1998.00116.x. Kidney Int. 1998. PMID: 9767534 Free article.

7

Expression of interleukin-8 in human glomerulonephritis.

Sekikawa T, Kashihara N, Maruyama K, Satoh M, Okamoto K, Kanao K, Maeshima Y, Sugiyama H, Yamasaki Y, Makino H. Sekikawa T, et al. Res Commun Mol Pathol Pharmacol. 1998 Feb;99(2):217-24. Res Commun Mol Pathol Pharmacol. 1998. PMID: 9583095

8

[The risk of adverse events of CPT- 11].

Imataka H, Sekikawa T, Ichikawa W. Imataka H, et al. Among authors: sekikawa t. Nihon Rinsho. 2016 Nov;74(11):1847-1851. Nihon Rinsho. 2016. PMID: 30550693 Japanese.

9

Second-line chemotherapy with biweekly paclitaxel after failure of fluoropyrimidine-based treatment in patients with advanced or recurrent gastric cancer: a report from the gastrointestinal oncology group of the Tokyo cooperative oncology group, TCOG GC-0501 trial.

Koizumi W, Akiya T, Sato A, Yamaguchi K, Sakuyama T, Nakayama N, Tanabe S, Higuchi K, Sasaki T, Sekikawa T; Tokyo Cooperative Oncology Group (TCOG GI Group). Koizumi W, et al. Among authors: sekikawa t. Jpn J Clin Oncol. 2009 Nov;39(11):713-9. doi: 10.1093/jjco/hyp099. Epub 2009 Oct 6. Jpn J Clin Oncol. 2009. PMID: 19812061 Clinical Trial.

10

A phase II study of bevacizumab with modified OPTIMOX1 as first-line therapy for metastatic colorectal cancer: the TCOG-GI 0802 study.

Nakayama N, Sato A, Tanaka S, Shimada K, Konishi K, Sasaki E, Hibi K, Ichikawa H, Kikuchi Y, Sakuyama T, Sekikawa T, Hayashi K, Nishina H; Tokyo Cooperative Oncology Group, Tokyo, Japan. Nakayama N, et al. Among authors: sekikawa t. Invest New Drugs. 2015 Aug;33(4):954-62. doi: 10.1007/s10637-015-0239-1. Epub 2015 May 5. Invest New Drugs. 2015. PMID: 25937430 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

161 results

Search Page

Filters